Theratechnologies Inc. (THTX) PT Raised to $8 at Canaccord Genuity

April 19, 2021 8:40 AM EDT
Get Alerts THTX Hot Sheet
Price: $3.71 +0.27%

Rating Summary:
    0 Buy, 1 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 14 | Down: 5 | New: 58
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Canaccord Genuity analyst Edward Nash raised the price target on Theratechnologies Inc. (NASDAQ: THTX) to $8.00 (from $7.00) while maintaining a Buy rating as the company ends 1Q21 with an improved re-aligned commercial strategy and a clear clinical path for NASH.

The analyst commented, "On Wednesday, April 14, Theratechnologies reported business highlights and financial results for 1Q21 ended February 28, 2021. The management team emphasized that the company would keep focusing on two critical objectives: advancing the clinical development pipeline programs in NASH and oncology, and growing the HIV commercial franchise."

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change

Related Entities

Earnings, Canaccord Genuity